As of 2025-07-09, the Relative Valuation of Oyster Point Pharma Inc (OYST) is (88.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.17 USD, the upside of Oyster Point Pharma Inc based on Relative Valuation is -889.4%.
The range of the Relative Valuation is (67.51) - (122.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 18.6x | 13.1x |
| Forward P/E multiples | 10.3x - 21.3x | 13.7x |
| Fair Price | (67.51) - (122.53) | (88.18) |
| Upside | -704.4% - -1196.9% | -889.4% |
| Date | P/E |